Risk for Cancer With Glucagon-Like Peptide-1 Receptor Agonists and Dual Agonists

Authors

Institutions

Publication Details

Journal
Annals of Internal Medicine
Published
2025-12-08
DOI
https://doi.org/10.7326/annals-25-02237
Citations
2
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
2.59
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Risk for Cancer With Glucagon-Like Peptide-1 Receptor Agonists and Dual Agonists

Tsu Hsien Wang, Cho‐Han Chiang, Furkan Bahar, Yuan Ping Hsia et al.
2 citations
Annals of Internal Medicine
Diabetes Treatment and Management
2.59
article

Risk for Cancer With Glucagon-Like Peptide-1 Receptor Agonists and Dual Agonists

Tsu Hsien Wang, Cho‐Han Chiang, Furkan Bahar, Yuan Ping Hsia, Chun-Chiao Yu, X.W. Xu, Xin Ya See, Rebecca Jen-Ling Hsieh, Nutchapon Xanthavanij, Shao‐Wei Lo, Cho‐Hung Chiang, Yu-Cheng Chang, Shuwen Lin, Albert Ko, Junmin Song
article en
2 citations

Abstract

No abstract available for this paper.
Annals of Internal MedicineVol. 179(2)
Mount Auburn Hospital (US), Montefiore Medical Center (US), Harvard University (US), Kaohsiung Medical University (TW), Danbury Hospital (US), Jacobi Medical Center (US), University of Vermont Medical Center (US), Taipei Tzu Chi Hospital (TW), Unity Health System (US), National Taiwan University Hospital (TW), Unity Hospital (US), University at Buffalo, State University of New York (US)
Openalex Percentile: Top 8%
Diabetes Treatment and Management
2.59
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.